Moreadith Randall
Serina Therapeutics, Inc. · Chief Scientific Officer
Moreadith Randall is listed in filings as Chief Scientific Officer at Serina Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including sale activity. Recent filings connect the profile to Serina Therapeutics, Inc. (SER). The current snapshot covers public activity from Jul 17, 2025 to May 26, 2026. Reported amounts are shown as $161.7K to $18.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.